GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Apollo Endosurgery Inc (NAS:APEN) » Definitions » PB Ratio

Apollo Endosurgery (Apollo Endosurgery) PB Ratio : 12.89 (As of May. 12, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Apollo Endosurgery PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-12), Apollo Endosurgery's share price is $10.00. Apollo Endosurgery's Book Value per Share for the quarter that ended in Dec. 2022 was $0.78. Hence, Apollo Endosurgery's PB Ratio of today is 12.89.

The historical rank and industry rank for Apollo Endosurgery's PB Ratio or its related term are showing as below:

APEN' s PB Ratio Range Over the Past 10 Years
Min: 0.41   Med: 3.82   Max: 93.68
Current: 12.89

During the past 13 years, Apollo Endosurgery's highest PB Ratio was 93.68. The lowest was 0.41. And the median was 3.82.

APEN's PB Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.235 vs APEN: 12.89

During the past 12 months, Apollo Endosurgery's average Book Value Per Share Growth Rate was -49.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 97.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -13.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -45.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Apollo Endosurgery was 124.60% per year. The lowest was -70.60% per year. And the median was -34.70% per year.

Back to Basics: PB Ratio


Apollo Endosurgery PB Ratio Historical Data

The historical data trend for Apollo Endosurgery's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollo Endosurgery PB Ratio Chart

Apollo Endosurgery Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.62 28.22 13.03 5.45 12.85

Apollo Endosurgery Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.45 4.41 3.07 5.41 12.85

Competitive Comparison of Apollo Endosurgery's PB Ratio

For the Medical Devices subindustry, Apollo Endosurgery's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apollo Endosurgery's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Apollo Endosurgery's PB Ratio distribution charts can be found below:

* The bar in red indicates where Apollo Endosurgery's PB Ratio falls into.



Apollo Endosurgery PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Apollo Endosurgery's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2022)
=10.00/0.776
=12.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Apollo Endosurgery  (NAS:APEN) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Apollo Endosurgery PB Ratio Related Terms

Thank you for viewing the detailed overview of Apollo Endosurgery's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Apollo Endosurgery (Apollo Endosurgery) Business Description

Traded in Other Exchanges
N/A
Address
1120 S. Capital of Texas Highway, Building 1, Suite 300, Austin, TX, USA, 78746
Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focuses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include the OverStitch Endoscopic Suturing System, X-Tack Endoscopic HeliX Tacking System, and the Orbera Intragastric Balloon System.
Executives
Antal Rohit Desai 10 percent owner C/O PROCEPT BIOROBOTICS CORPORATION, 900 ISLAND DRIVE, REDWOOD CITY CA 94065
Sharon O'keefe director C/O VOCERA COMMUNICATIONS, INC., 525 RACE STREET, SAN JOSE CA 95126
Jeannette Bankes director ONE ALLENTOWN PARKWAY, ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Jeffrey G. Black officer: Chief Financial Officer 4955 DIRECTORS PLACE, SAN DIEGO CA 92121
Mike Gutteridge officer: VP, Int'l Sales and Marketing 1120 S. CAPITAL OF TEXAS HIGHWAY, BUILDING 1, SUITE #300, AUSTIN TX 78746
Cpmg Inc 10 percent owner 4215 WEST LOVERS LANE, SUITE 100, DALLAS TX 75209
Mcgaughy R Kent Jr director, 10 percent owner 500 CRESCENT COURT, SUITE 250, DALLAS TX 75201
Chas Mckhann director, officer: President and CEO 1555 ADAMS DRIVE, C/O INTERSECT ENT, INC., MENLO PARK CA 94025
David Pacitti director C/O APOLLO ENDOSURGERY, INC., 1120 S., CAPITAL OF TEXAS HWY, BLDG. 1, SUITE 300, AUSTIN TX 78746
John R Barr director VI TECHNOLOGIES INC, 134 COOLIDGE AVENUE, WATERTOWN MA 02472
Neil Gagnon 10 percent owner 1370 AVENUE OF THE AMERICAS, 24TH FLOOR, NEW YORK NY 10019
Traweek James W Jr 10 percent owner 2000 MCKINNEY AVE, SUITE 2125, DALLAS TX 75201
Todd Newton director, officer: Chief Executive Officer 1120 S CAPITAL OF TX HWY, BUILDING ONE, STE 300, AUSTIN TX 78746
Stonepine Capital, L.p. 10 percent owner 919 NW BOND STREET, SUITE 204, BEND OR 97703
Matthew S Crawford director, 10 percent owner 3600 N CAPITAL OF TEXAS HWY, SUITE B180, AUSTIN TX 78746

Apollo Endosurgery (Apollo Endosurgery) Headlines

From GuruFocus